RAC1 and melanoma: In the present study, a novel nine-ERG signature, including CSTB, CEBPB, GBF1, TYR, RAC1, PML, SLC2A1, ICAM1 and NOTCH3, was built to effectively predict the prognosis of patients with melanoma.